In the midst of turbulent economic times, and at a moment when the U.S. is looking to encourage technology job creation in the coming decade, an increasing number of public and private sector initiatives have been proposed to spur job creation. While the U.S. leads in the area of biotechnology, there is no guarantee that this competitive edge will continue. Moreover, although the U.S. is more prolific in life science discoveries than any other single country in the world, there is a sense that many of these discoveries do not make it to the market place. Experts believe that it is through commercialization of these early stage discoveries, that the U.S. will be able to jump start job creation.
BIO’s Technology Transfer Symposium will explore proposals and initiatives intended to do this through the lens of a biotechnology innovator/entrepreneur. This leadership forum will explore the policies and initiatives that are necessary to position more university innovations for effective partnering and commercialization. Leaders in state, federal and regional governments, academia, industry and non-profit philanthropic organizations will discuss how they propose to translate early stage discoveries into jobs, products and ultimately economic growth for their region.
Here’s a look at the agenda:
1:00-1:10 Welcome and Introductions by BIO’s Technology Transfer Committee Chair
Mark Crowell, Executive Director and Associate Vice President for Innovation Partnerships and Commercialization, University of Virginia
1:15- 1:45 Keynote
Clearing the Path to Market for University Research by Leveraging Regional Ecosystem Development and Streamlined Technology Licensing
2:00-3:00 Panel Discussion
Enhancing America’s Competitive Edge
A panel of experts will explore ways that the U.S. can leverage its strengths to enhance its competitive edge in an increasingly challenging global environment.
Moderator: Richard Gallagher, Editor, Scientific American Worldview
Gail Maderis, President and CEO of BayBIO
Doug Crawford, QB3, UCSF
3:00-4:00 Panel Discussion
Navigating Funding and Policy Barriers to Medical Innovation
A panel of experts will discuss some possible ways to navigate current funding or policy barriers in biomedical innovation.
Moderator: Janet Embretson, Ph.D., Schwegman, Lundberg and Woessner
Margaret Anderson, Executive Director, FasterCures
Duane J. Roth, Chief Executive Officer, CONNECT
Aron Knickerbocker, Vice President Business Development, Five Prime
Jodi B. Black, Ph.D., Deputy Director, Division of Extramural Research Activities, National, Heart, Lung, and Blood Institute, NIH
4:00-4:30 Concluding Speaker
Janet Embretson, Ph.D., Schwegman, Lundberg and Woessner
4:30-6:30 Networking Reception
October 24, 2011 ▪ 1:00–4:30 p.m. Pacific Time
Co-Located with BIO Investor Forum
The Palace Hotel – Twin Peaks Room
2 Montgomery Street
San Francisco, California 94105